Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Insomnia is a frequent co-morbidity of many mental disorders: Almost 70% of patients with mental disorders find it difficult to fall asleep or maintain sleep. Insomnia increases the risk of a negative course of the mental disorder and of poorer treatment efficacy. Cognitive behavioural therapy for insomnia (CBT-I) is effective for the reduction of insomnia in this patient group and has been recommended as a first-line treatment in European and American treatment guidelines. Among different mental disorders, depression is the best investigated co-morbidity (see Chapter 12). A wide range of studies demonstrates the efficacy of CBT-I for the reduction of insomnia. Whereas some studies found a positive effect of CBT-I also on depressive symptoms, other studies could not replicate these effects. Treatment efficacy of CBT-I has also been demonstrated for patients with post-traumatic stress disorder, bipolar disorder and schizophrenia. For depression, bipolar disorder and schizophrenia, research suggests that CBT-I may contribute to the prevention of further episodes of the disease. More research is needed to evaluate the efficacy of CBT-I for patients with yet under-investigated co-morbidities such as ADHD.

Original publication





Book title

Cognitive-Behavioural Therapy for Insomnia (CBT-I) Across the Life Span: Guidelines and Clinical Protocols for Health Professionals

Publication Date



151 - 160